Canadian Pharmacogenomics Network for Drug Safety (CPNDS), Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Registration Status: Completed

Objective: Biological specimens collected for the purposes of genomic analysis of medication outcomes.

Registered Biobank Name	Canadian Pharmacogenomics Network for Drug Safety (CPNDS)
Biobank Leader	Dr. Bruce Carleton
Country	Canada
Email for biobank inquiries	bcarleton@popi.ubc.ca
Principal Investigator	Dr. Bruce Carleton
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected: